Restrepo Valencia CA, Chacón JA, Ospina Jiménez JI. Hyperpotassemia secondary to the combined use of an ACEI or ARB II with spironolactone. Rev Nefrol Dial Traspl. [Internet]. 2023Dec.7 [cited 2024May20];43(04):228-35. Available from: http://www.revistarenal.org.ar/index.php/rndt/article/view/949